DA Davidson lowered the firm’s price target on Vertex (VERX) to $50 from $55 and keeps a Buy rating on the shares as part of a broader research ...

Morgan Stanley lowered the firm’s price target on Vertex (VERX) to $55 from $60 and keeps an Overweight rating on the shares. The firm is ...

Significant progress in aircraft design and expansion of IP portfolio sets stage for 2025 pre-orders and FAA certification advancement XTI Aerospace Logo (PRNewsfoto/XTI Aerospace, Inc.) "2024 ...

The aviation and aerospace industry demands extreme precision and stringent safety standards, with various filtration systems playing a crucial role in protecting passengers and ensuring optimal ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Animal locomotion is fundamentally built upon reciprocal, cyclic motion, which provides efficiency, low-control complexity and adaptability to the environment. Song Li and colleagues introduce ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Boeing employees don’t trust senior leadership and don’t feel their contributions are recognized. The company has five new values it will adopt to work on changing its culture.